A recent study examined the association between high and low exposure to statins and the incidence of Alzheimer disease for men and women of various races/ethnicities.
Researchers sought to determine if odor identification might be a useful supplementary screening tool for diagnosing Alzheimer disease and mild cognitive impairment.